<mods:mods version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mods="http://www.loc.gov/mods/v3"><mods:titleInfo><mods:title>CHANGES IN THE MAMMARY GLANDS IN WOMEN WITH THYROID DISORDERS</mods:title></mods:titleInfo><mods:name type="personal"><mods:namePart type="given">Rustamova</mods:namePart><mods:namePart type="family">Saodat</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:name type="personal"><mods:namePart type="given">Yuldashev</mods:namePart><mods:namePart type="family">Otabek</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:abstract>Thyroid disorders are highly prevalent endocrine conditions among women and exert a systemic influence on multiple organs, including the mammary glands. The close physiological relationship between thyroid hormones, prolactin, and sex steroids plays a crucial role in breast tissue development and function. Dysregulation of thyroid function may lead to proliferative, structural, and functional alterations in the mammary glands, increasing the incidence of benign breast diseases. This study aimed to comprehensively evaluate changes in the mammary glands in women with thyroid disorders based on clinical, hormonal, and ultrasonographic findings obtained at the Khorezm branch of the Republican specialized scientific and practical medical center of endocrinology. The results demonstrate a high prevalence of breast tissue changes in patients with thyroid dysfunction, emphasizing the need for early diagnosis and multidisciplinary management.</mods:abstract><mods:originInfo><mods:dateIssued encoding="iso8601">2026-01-07</mods:dateIssued></mods:originInfo><mods:originInfo><mods:publisher>Center for Tech and Media Research</mods:publisher></mods:originInfo><mods:genre>Maqola</mods:genre></mods:mods>